Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 18Takeda Pharmaceutical

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

FRUQUINTINIB

Brand Name : FRUZAQLA

Dosage Form : CAPSULE;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 2023-11-08

Application Number : 217564

Regulatory Info : RX

Registration Country : USA

blank

02

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

FRUQUINTINIB

Brand Name : FRUZAQLA

Dosage Form : CAPSULE;ORAL

Dosage Strength : 5MG

Packaging :

Approval Date : 2023-11-08

Application Number : 217564

Regulatory Info : RX

Registration Country : USA

blank

03

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Fruquintinibum

Brand Name : Fruzaqla

Dosage Form : Hard Capsule

Dosage Strength : 1mg

Packaging :

Approval Date : 27/08/2024

Application Number : 69524

Regulatory Info : Allowed

Registration Country : Switzerland

blank

04

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Fruquintinibum

Brand Name : Fruzaqla

Dosage Form : Hard Capsule

Dosage Strength : 5mg

Packaging :

Approval Date : 27/08/2024

Application Number : 69524

Regulatory Info : Allowed

Registration Country : Switzerland

blank

05

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Frukvintinib

Brand Name : Fruzaqla

Dosage Form : Capsule

Dosage Strength : 1mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

06

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Frukvintinib

Brand Name : Fruzaqla

Dosage Form : Capsule

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

07

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Fruquintinib

Brand Name : Fruzaqla

Dosage Form : Capsule

Dosage Strength : 1mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

08

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Fruquintinib

Brand Name : Fruzaqla

Dosage Form : Capsule

Dosage Strength : 5mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

09

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Fruquintinib

Brand Name : Fruzaqla

Dosage Form : Hard Capsule

Dosage Strength : 1MG

Packaging :

Approval Date : 26-06-2024

Application Number : 1241827001

Regulatory Info : Authorized

Registration Country : Spain

blank

10

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Fruquintinib

Brand Name : Fruzaqla

Dosage Form : Hard Capsule

Dosage Strength : 5MG

Packaging :

Approval Date : 26-06-2024

Application Number : 1241827002

Regulatory Info : Authorized

Registration Country : Spain

blank

11

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Fruquintinib

Brand Name : Fruzaqla

Dosage Form : Hard Capsules

Dosage Strength : 5mg

Packaging :

Approval Date : 20-06-2024

Application Number : 28106981523

Regulatory Info : Prescription

Registration Country : Denmark

blank

12

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Fruquintinib

Brand Name : Fruzaqla

Dosage Form : Hard Capsules

Dosage Strength :

Packaging :

Approval Date : 20-06-2024

Application Number : 28106981423

Regulatory Info : Prescription

Registration Country : Denmark

blank

13

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Fruquintinib (Frukintinib)

Brand Name : Fruzaqla

Dosage Form : Capsule

Dosage Strength :

Packaging :

Approval Date : 25-06-2024

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

14

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Fruquintinib (Frukintinib)

Brand Name : Fruzaqla

Dosage Form : Capsule

Dosage Strength : 5mg

Packaging :

Approval Date : 25-06-2024

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

15

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Fruquintinib

Brand Name : Fruzaqla

Dosage Form :

Dosage Strength :

Packaging : 21

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

16

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Fruquintinib

Brand Name : Fruzaqla

Dosage Form :

Dosage Strength :

Packaging : 21

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

17

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

FRUQUINTINIB

Brand Name : FRUZAQLA

Dosage Form : CAPSULE

Dosage Strength : 1MG

Packaging :

Approval Date :

Application Number : 2551454

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

18

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

FRUQUINTINIB

Brand Name : FRUZAQLA

Dosage Form : CAPSULE

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number : 2551462

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank